KIPA shows promise in predicting chemotherapy response in triple negative breast cancer
Researchers at Baylor College of Medicine and collaborating institutions are developing a strategy to predict the response of triple negative breast cancer (TNBC) to chemotherapy, which would be a valuable tool for physicians deciding on the treatment with better probability of success on an individual basis.
Source: news-medical.net
